380 related articles for article (PubMed ID: 32862739)
21. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
22. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
[TBL] [Abstract][Full Text] [Related]
23. MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway.
Liu Y; Ma Z; Huang Z; Zou D; Li J; Feng P
Ren Fail; 2022 Dec; 44(1):191-203. PubMed ID: 35170385
[TBL] [Abstract][Full Text] [Related]
24. miR-15a-5p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting VEGF in rats.
He Q; Wen L; Wang L; Zhang Y; Yu W; Zhang F; Zhang W; Xiao J; Wen X; Zhao Z
Ren Fail; 2020 Nov; 42(1):932-943. PubMed ID: 32909490
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.
Catar RA; Bartosova M; Kawka E; Chen L; Marinovic I; Zhang C; Zhao H; Wu D; Zickler D; Stadnik H; Karczewski M; Kamhieh-Milz J; Jörres A; Moll G; Schmitt CP; Witowski J
Front Immunol; 2022; 13():821681. PubMed ID: 35185912
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
28. Tubastatin alleviates epidural fibrosis via negatively targeting TGFβ/PI3K/Akt pathway.
Tao L; Wu L; Ge Y
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):231-236. PubMed ID: 38678601
[TBL] [Abstract][Full Text] [Related]
29. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
30. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
31. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
32. Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells.
Aihara S; Nakano T; Torisu K; Kitazono T
Clin Exp Nephrol; 2022 Dec; 26(12):1160-1169. PubMed ID: 36070106
[TBL] [Abstract][Full Text] [Related]
33. Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.
Abrahams AC; Habib SM; Dendooven A; Riser BL; van der Veer JW; Toorop RJ; Betjes MG; Verhaar MC; Watson CJ; Nguyen TQ; Boer WH
PLoS One; 2014; 9(11):e112050. PubMed ID: 25384022
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
[TBL] [Abstract][Full Text] [Related]
35. The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells.
Lee SH; Kang HY; Kim KS; Nam BY; Paeng J; Kim S; Li JJ; Park JT; Kim DK; Han SH; Yoo TH; Kang SW
Lab Invest; 2012 Dec; 92(12):1698-711. PubMed ID: 23007133
[TBL] [Abstract][Full Text] [Related]
36. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
37. IL-6 Trans-Signaling Links Inflammation with Angiogenesis in the Peritoneal Membrane.
Catar R; Witowski J; Zhu N; Lücht C; Derrac Soria A; Uceda Fernandez J; Chen L; Jones SA; Fielding CA; Rudolf A; Topley N; Dragun D; Jörres A
J Am Soc Nephrol; 2017 Apr; 28(4):1188-1199. PubMed ID: 27837150
[TBL] [Abstract][Full Text] [Related]
38. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
[TBL] [Abstract][Full Text] [Related]
39. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
Washida N; Wakino S; Tonozuka Y; Homma K; Tokuyama H; Hara Y; Hasegawa K; Minakuchi H; Fujimura K; Hosoya K; Hayashi K; Itoh H
Nephrol Dial Transplant; 2011 Sep; 26(9):2770-9. PubMed ID: 21378147
[TBL] [Abstract][Full Text] [Related]
40. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]